Motif Bio medical chief to present at prestigious infectious diseases conference

03:24 EDT 22 Jun 2017 | Proactive Investors

Motif Bio Plc (LON:MTFB) said its chief medical officer has been invited to address a prestigious conference to discuss the results of the first of two clinical trials of iclaprim, its next-generation antibiotic. Dr David Huang will present at IDWeek 2017 on October 7 where he will give an overview of the REVIVE-1 phase-III clinical study. "IDWeek is a major event for infectious disease professionals and I am delighted that the IDWeek Committee have selected iclaprim for presentation,” said Huang. “I look forward to presenting the positive data from the REVIVE-1 trial.  “We believe these data suggest iclaprim may serve as an important differentiated antibiotic option in an era of emerging antibiotic resistant infections." Positive result In April Motif successfully completed the final-stage assessment of the drug and its ability to treat patients with acute bacterial skin and skin structure infections (ABSSSI). The top-line results revealed it scored well against one of the leading products, vancomycin, on two counts. Researchers were assessing whether iclaprim was ‘non-inferior’ to vancomycin in the 48 to 72 hours after the start of administration and at the test of cure, a week to a fortnight after patients stop receiving treatment. It also did well in meeting several secondary ‘endpoints’, investors were told. Kidney disease boost Data from REVIVE-2, the second phase III trial, which uses an identical protocol but has different trial centres, are expected in the second half of the year. Motif plans to make a new drug application in the first half of 2018. It is thought iclaprim could be an important treatment for patients with ABSSSI who may have kidney disease – which is around a quarter of the 3.6mln annually that catch the infection.

Original Article: Motif Bio medical chief to present at prestigious infectious diseases conference


More From BioPortfolio on "Motif Bio medical chief to present at prestigious infectious diseases conference"

Quick Search


Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...